Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wallaert

Showing results (131-140 of 398) with videos related to

Pageof 40
Sort By:
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in pulmonary histiocytosis XC Danel, D Israel-Biet, U Costabel, et al.
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in alveolar proteinosisC Danel, D Israel-Biet, U Costabel, et al.
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in eosinophilic lung diseasesC Danel, D Israel-Biet, U Costabel, et al.
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in pulmonary haemorrhagesC Danel, D Israel-Biet, U Costabel, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2005
Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosisM O Husson, N Wizla-Derambure, D Turck, et al.
Journal of Endourology|February 23, 2013
Insurance status, stone composition, and 24-hour urine compositionBenjamin W Herrick, Jessica B Wallaert, Brian H Eisner, et al.
Revue Des Maladies Respiratoires|November 6, 2002
[Unusual etiologies of multiple pulmonary opacities]J Y Tavernier, M C Copin, M Bure, et al.
Revue Des Maladies Respiratoires|July 5, 2003
[Unusual progression of pulmonary opaque cavitation]C Zanetti, N Just, S Leroy, et al.
American Journal of Respiratory Cell and Molecular Biology|November 1, 1991
Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar macrophages from healthy smokers requires the presence of myeloperoxidaseB Wallaert, B Gressier, C Aerts, et al.
Chest|February 1, 1985
Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDSF Fourrier, C Chopin, B Wallaert, et al.
Pageof 40

Showing results (131-140 of 398) with videos related to

Sort By:
Pageof 40
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in pulmonary histiocytosis XC Danel, D Israel-Biet, U Costabel, et al.
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in alveolar proteinosisC Danel, D Israel-Biet, U Costabel, et al.
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in eosinophilic lung diseasesC Danel, D Israel-Biet, U Costabel, et al.
The European Respiratory Journal|September 1, 1990
The clinical role of BAL in pulmonary haemorrhagesC Danel, D Israel-Biet, U Costabel, et al.
The Journal of Antimicrobial Chemotherapy|June 4, 2005
Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosisM O Husson, N Wizla-Derambure, D Turck, et al.
Journal of Endourology|February 23, 2013
Insurance status, stone composition, and 24-hour urine compositionBenjamin W Herrick, Jessica B Wallaert, Brian H Eisner, et al.
Revue Des Maladies Respiratoires|November 6, 2002
[Unusual etiologies of multiple pulmonary opacities]J Y Tavernier, M C Copin, M Bure, et al.
Revue Des Maladies Respiratoires|July 5, 2003
[Unusual progression of pulmonary opaque cavitation]C Zanetti, N Just, S Leroy, et al.
American Journal of Respiratory Cell and Molecular Biology|November 1, 1991
Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar macrophages from healthy smokers requires the presence of myeloperoxidaseB Wallaert, B Gressier, C Aerts, et al.
Chest|February 1, 1985
Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDSF Fourrier, C Chopin, B Wallaert, et al.
Pageof 40